Literature DB >> 19004443

Inflammatory and thrombotic processes are associated with vascular dysfunction in children with familial hypercholesterolemia.

Marietta Charakida1, Dimitris Tousoulis, Ioannis Skoumas, Christos Pitsavos, Carmen Vasiliadou, Elli Stefanadi, Charalambos Antoniades, George Latsios, Gerasimos Siasos, Christodoulos Stefanadis.   

Abstract

BACKGROUND: Evidence suggests that children with familial hypercholesterolemia (FH) have endothelial dysfunction. Inflammatory and haemostatic abnormalities are associated with advanced atherosclerosis and increased cardiovascular events. However, it is unknown whether these abnormalities present in FH children and contribute to their vascular dysfunction. METHODS AND
RESULTS: We studied 38 children with FH (19 males, 19 females aged 14.8+/-0.9 years mean+/-S.E.) and 41 healthy children (controls; 22 males, 19 females aged 15.4+/-0.7 years). Endothelium-dependent reactive hyperemia (RH%) and endothelium-independent nitrate hyperemia dilatation (NH%) were measured by strain gauge plethysmography. Inflammatory and haemostatic parameters were assessed by ELISA. RH% and NH% were significantly reduced in FH compared to controls (91.3+/-9.3% vs. 120.4+/-10.6% and 53.6+/-3.8% vs. 74.5+/-7.4%, p<0.05 for both). Total cholesterol and lipoprotein (a) were increased in FH children compared to controls (282.3+/-8.8 mg/dl vs. 163.8+/-4.6 mg/dl and 11.0[4.6, 30.7]mg/dl vs. 5.24[2.63, 11.0]mg/dl median [IQR] respectively; p<0.001 for both). Intercellular cell adhesion molecule (ICAM-1) and interleukin 1 beta (IL-1 beta) serum levels were increased in FH compared to controls (p<0.05 and <0.001, respectively). Plasminogen activator inhibitor 1 (PAI-1) levels were also higher in FH children (p<0.001). Multivariate analysis revealed that reactive hyperemia was independently associated with nitrate-dependent reactive hyperemia (beta=0.597(0.199), p<0.01), PAI-1(beta=-6.78(2.65), p<0.05), log IL-1 beta (beta=-102.8 (30.2), p<0.01), age (beta=-5.06 (2.35), p<0.05) and FH status (beta=-25.2(10.6), p<0.05) (R(2) for the model: 0.63, p=0.001).
CONCLUSIONS: Inflammatory and haemostatic abnormalities are present in FH children and contribute to the endothelial dysfunction observed in these children.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19004443     DOI: 10.1016/j.atherosclerosis.2008.09.025

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  Il6 gene promoter polymorphism (-174G/C) influences the association between fat mass and cardiovascular risk factors.

Authors:  A Moleres; T Rendo-Urteaga; C Azcona; J A Martínez; S Gómez-Martínez; J R Ruiz; L A Moreno; A Marcos; A Marti
Journal:  J Physiol Biochem       Date:  2009-12       Impact factor: 4.158

2.  Early onset of coronary heart disease in a young woman with familial hypercholesterolemia: coronary findings and effect of short term treatment with high dose atorvastatin.

Authors:  Natale Daniele Brunetti; Deodata Montrone; Riccardo Ieva; Antonio Ruggiero; Michele Correale; Luisa De Gennaro; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

Review 3.  Systemic Inflammation, Oxidative Stress and Cardiovascular Health in Children and Adolescents: A Systematic Review.

Authors:  Tjaša Hertiš Petek; Tadej Petek; Mirjam Močnik; Nataša Marčun Varda
Journal:  Antioxidants (Basel)       Date:  2022-04-30

Review 4.  Impact of Health Status and Lifestyle Modifications on Vascular Structure and Function in Children and Adolescents.

Authors:  Donald R Dengel; Justin R Ryder
Journal:  Am J Lifestyle Med       Date:  2015-08-26

5.  Italian consensus statement on paediatric HIV infection.

Authors:  C Giaquinto; M Penazzato; R Rosso; S Bernardi; O Rampon; P Nasta; A Ammassari; A Antinori; R Badolato; G Castelli Gattinara; A d'Arminio Monforte; M De Martino; A De Rossi; P Di Gregorio; S Esposito; F Fatuzzo; S Fiore; A Franco; C Gabiano; L Galli; O Genovese; V Giacomet; A Giannattasio; C Gotta; A Guarino; A Martino; F Mazzotta; N Principi; M B Regazzi; P Rossi; R Russo; M Saitta; F Salvini; S Trotta; A Viganò; G Zuccotti; G Carosi
Journal:  Infection       Date:  2010-06-01       Impact factor: 7.455

6.  Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting.

Authors:  Roberto Scicali; Antonino Di Pino; Viviana Ferrara; Agata Maria Rabuazzo; Francesco Purrello; Salvatore Piro
Journal:  Acta Diabetol       Date:  2021-03-21       Impact factor: 4.280

7.  Longitudinal evaluation of endothelial markers in children and adolescents with familial hypercholesterolemia.

Authors:  Patrizia Bruzzi; Barbara Predieri; Simona Madeo; Francesca Lami; Lorenzo Iughetti
Journal:  Acta Biomed       Date:  2021-11-03

8.  HELP LDL apheresis reduces plasma pentraxin 3 in familial hypercholesterolemia.

Authors:  Michela Zanetti; Mariagrazia Zenti; Rocco Barazzoni; Federica Zardi; Annamaria Semolic; Michele Giuseppe Messa; Filippo Mearelli; Gianpaolo Russi; Maurizio Fonda; Luca Scarano; Enzo Bonora; Luigi Cattin
Journal:  PLoS One       Date:  2014-07-11       Impact factor: 3.240

9.  Enhanced status of inflammation and endothelial activation in subjects with familial hypercholesterolaemia and their related unaffected family members: a case control study.

Authors:  Thuhairah Rahman; Nur Suhana Hamzan; Atiqah Mokhsin; Radzi Rahmat; Zubin Othman Ibrahim; Rafezah Razali; Malathi Thevarajah; Hapizah Nawawi
Journal:  Lipids Health Dis       Date:  2017-04-24       Impact factor: 3.876

10.  Prevention of endothelial dysfunction and thrombotic events in COVID-19 patients with familial hypercholesterolemia.

Authors:  Alpo Vuorio; Petri T Kovanen
Journal:  J Clin Lipidol       Date:  2020-06-15       Impact factor: 4.766

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.